title: Candidate genes and potential targets for therapeutics in Wilms' tumour.
abstract: Wilms' tumour (WT) is the most common malignant renal tumour of childhood. During the past two decades or so, molecular studies carried out on biopsy specimens and tumour-derived cell lines have identified a multitude of chromosomal and epigenetic alterations in WT. In addition, a significant amount of evidence has been gathered to identify the genes and signalling pathways that play a defining role in its genesis, growth, survival and treatment responsiveness. As such, these molecules and mechanisms constitute potential targets for novel therapeutic strategies for refractory WT. In this report we aim to review some of the many candidate genes and intersecting pathways that underlie the complexities of WT biology.
authors.affiliation: Southern Alberta Children's Cancer Program, Alberta Children's Hospital, Calgary, Alberta, Canada.
authors.forename: Christopher
authors.initials: C
authors.lastname: Blackmore
authors.forename: Max J
authors.initials: MJ
authors.lastname: Coppes
authors.forename: Aru
authors.initials: A
authors.lastname: Narendran
mesh_terms: D002869:Chromosome Aberrations; D015972:Gene Expression Regulation, Neoplastic; D052138:Genes, Neoplasm; D056426:Genetic Loci; D006801:Humans; D058990:Molecular Targeted Therapy; D015398:Signal Transduction; D009396:Wilms Tumor / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology